IMPACT BIOMEDICAL INC. (IBO)
Data as of , from SEC Form 4 filings.
See up to 3 months of IBO. The 7-day demo opens the 1M and 3M ranges and puts IBO on your watchlist.
Start 7-day demoLatest IBO insider trades
Todd D. Macko - OfficerOpen-market sale$961- Todd D. Macko - OfficerOpen-market sale$24K
- Jason Grady - DirectorOpen-market sale$33K
- DSS, INC. - 10% OwnerOpen-market sale$63K
- DSS, INC. - 10% OwnerOpen-market sale$25K
- Heng Fai Ambrose Chan - DirectorOpen-market sale$174K
- Heng Fai Ambrose Chan - DirectorOpen-market sale$174K
- Heng Fai Ambrose Chan - DirectorOpen-market sale$135K
About IMPACT BIOMEDICAL INC. (IBO)
IMPACT BIOMEDICAL INC. is an SEC registrant, filing under CIK 0001834105, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
IBO Form 4 activity by transaction type, last 90 days
No Form 4 activity for IBO in the last 90 days.
IBO insider transactions (Form 4)
239 Form 4 filings on record, the earliest from Nov 22, 2024, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Todd D. Macko - Officer | Open-market sale | Common Stock | 1,600 | $0.60 | $961 | |
| Todd D. Macko - Officer | Open-market sale | Common Stock | 43,400 | $0.56 | $24K | |
| Jason Grady - Director | Open-market sale | Common Stock | 50,000 | $0.65 | $33K | |
| DSS, INC. - 10% Owner | Open-market sale | Common Stock | 115,600 | $0.55 | $63K | |
| DSS, INC. - 10% Owner | Open-market sale | Common Stock | 45,400 | $0.54 | $25K | |
| Heng Fai Ambrose Chan - Director | Open-market sale | Common stock | 351,555 | $0.50 | $174K | |
| Heng Fai Ambrose Chan - Director | Open-market sale | Common stock | 300,000 | $0.58 | $174K | |
| Heng Fai Ambrose Chan - Director | Open-market sale | Common stock | 200,000 | $0.67 | $135K | |
| Heng Fai Ambrose Chan - Director | Open-market sale | Common stock | 2,349 | $0.67 | $2K | |
| Heng Fai Ambrose Chan - Director | Open-market sale | Common stock | 382,427 | $0.58 | $223K | |
| Heng Fai Ambrose Chan - Director | Open-market sale | Common stock | 351,631 | $0.58 | $204K | |
| Heng Fai Ambrose Chan - Director | Open-market sale | Common stock | 273,286 | $0.78 | $213K | |
| Heng Fai Ambrose Chan - Director | Open-market sale | Common stock | 180,000 | $0.96 | $173K | |
| Heng Fai Ambrose Chan - Director | Open-market sale | Common Stock | 300,000 | $1.03 | $308K | |
| Heng Fai Ambrose Chan - Director | Open-market sale | Common stock | 400,000 | $0.98 | $393K | |
| Heng Fai Ambrose Chan - Director | Open-market sale | Common Stock | 650,000 | $1.45 | $941K | |
| Heng Fai Ambrose Chan - Director | Open-market sale | Common Stock | 1,176,918 | $1.08 | $1.27M | |
| Frank D. Heuszel - Officer | Open-market purchase | Common Stock | 500 | $2.26 | $1K | |
| Frank D. Heuszel - Officer | Open-market purchase | Common Stock | 550 | $2.63 | $1K | |
| Frank D. Heuszel - Officer | Open-market purchase | Common Stock | 500 | $2.59 | $1K | |
| DSS, INC. - 10% Owner | Open-market sale | Common Stock | 500 | $2.76 | $1K | |
| DSS, INC. - 10% Owner | Open-market sale | Common Stock | 200 | $2.80 | $560 | |
| DSS, INC. - 10% Owner | Open-market sale | Common Stock | 5,000 | $3.02 | $15K |
Recent IBO Form 144 notices of proposed sale
1An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
IBO insider trading FAQ
What is the latest insider trade for IBO?
IMPACT BIOMEDICAL INC. (IBO) has filed no insider reports in the last 90 days. The most recent on record is dated 31 March 2026. The full record for IBO runs to 9 Form 4 filings, the earliest from 22 November 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying IBO stock?
No insider purchases of IBO were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling IBO stock?
No insider sales of IBO were filed in the last 90 days. 20 sales are on record for this company.
Where can I see IBO SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects IBO Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
9The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Todd D. Macko view on EDGAR
- - Jason Grady view on EDGAR
- - DSS, INC. view on EDGAR
- - Heng Fai Ambrose Chan view on EDGAR
- - Heng Fai Ambrose Chan view on EDGAR
- - Heng Fai Ambrose Chan view on EDGAR
- - Frank D. Heuszel view on EDGAR
- - Frank D. Heuszel view on EDGAR
- - DSS, INC. view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where IBO's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow IBO with a 7-day demo
- IBO on your watchlist
- Every IBO Form 4 filing on record
- Up to 3 months of IBO price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive